Free Trial

Neuphoria Therapeutics (NEUP) Institutional Ownership

Neuphoria Therapeutics logo
$4.96 -0.13 (-2.55%)
As of 03:05 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Neuphoria Therapeutics (NASDAQ:NEUP)

Current
Institutional Ownership
Percentage
15.90%
Number of
Institutional Buyers
(last 12 months)
12
Total
Institutional Inflows
(last 12 months)
$1.42M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$121.79K
Get NEUP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neuphoria Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

NEUP Institutional Buying and Selling by Quarter

Neuphoria Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/28/2026 AdvisorShares Investments LLC155,367$632K0.1%+15.8%2.882%
2/18/2026XTX Topco Ltd12,008$47K0.0%N/A0.223%
2/18/2026Ikarian Capital LLC47,443$184K0.0%N/A0.882%
2/18/2026Boothbay Fund Management LLC14,000$54K0.0%N/A0.260%
2/18/2026Bridgeway Capital Management LLC14,750$57K0.0%N/A0.274%
2/17/2026ADAR1 Capital Management LLC30,000$116K0.0%N/A0.558%
2/17/2026Diadema Partners LP50,000$194K0.0%+133.1%0.930%
2/17/2026 Persistent Asset Partners Ltd13,403$52K0.0%+173.1%0.249%
2/12/2026 Commonwealth Equity Services LLC11,207$43K0.0%N/A0.208%
2/10/2026 AdvisorShares Investments LLC134,194$521K0.1%+129.1%2.494%
2/9/2026Geode Capital Management LLC17,303$67K0.0%+33.3%0.322%
1/16/2026 FNY Investment Advisers LLC26,500$102K0.0%N/A0.493%
11/17/2025Millennium Management LLC18,329$216K0.0%N/A0.777%
11/10/2025 Persistent Asset Partners Ltd4,908$58K0.0%N/A0.208%
11/5/2025 AdvisorShares Investments LLC58,563$690K0.1%-13.5%2.484%
8/4/2025 AdvisorShares Investments LLC67,733$481K0.1%-2.8%3.603%
4/17/2025Cyndeo Wealth Partners LLC10,000$58K0.0%N/A0.569%
2/14/2025Jane Street Group LLC13,311$46K0.0%N/A0.817%
2/14/2025Lynx1 Capital Management LP45,806$157K0.1%N/A2.810%


NEUP Institutional Ownership - Frequently Asked Questions

During the previous two years, 15 institutional investors and hedge funds held shares of Neuphoria Therapeutics. The most heavily invested institutionals were AdvisorShares Investments LLC ($632K), Millennium Management LLC ($216K), Diadema Partners LP ($194K), Ikarian Capital LLC ($184K), Lynx1 Capital Management LP ($157K), ADAR1 Capital Management LLC ($116K), and FNY Investment Advisers LLC ($102K).Learn more on Neuphoria Therapeutics' institutional investors.

15.90% of Neuphoria Therapeutics' stock is owned by institutional investors. Learn more on NEUP's institutional investor holdings.

Of the 15 institutional investors that purchased Neuphoria Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AdvisorShares Investments LLC ($96.80K), Ikarian Capital LLC ($47.44K), Lynx1 Capital Management LP ($45.81K), ADAR1 Capital Management LLC ($30K), Diadema Partners LP ($28.55K), FNY Investment Advisers LLC ($26.50K), and Millennium Management LLC ($18.33K).

Institutional investors have bought a total of 317,317 shares in the last 24 months. This purchase volume represents approximately $1.42M in transactions.

The following institutional investors have sold Neuphoria Therapeutics stock in the last 24 months: AdvisorShares Investments LLC ($11.10K).

Institutional investors have sold a total of 11,096 shares in the last 24 months. This volume of shares sold represents approximately $121.79K in transactions.



This page (NASDAQ:NEUP) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners